NCT07000149
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07000149
Title A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC (eVOLVE-RCC02)
Acronym eVOLVE-RCC02
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site La Jolla California 92037 United States Details
Research Site Aurora Colorado 80045 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site New York New York 10065 United States Details
Research Site Cleveland Ohio 44106 United States Details
Research Site Nashville Tennessee 37232 United States Details
Research Site Lubbock Texas 79430 United States Details
Research Site East Melbourne 3002 Australia Details
Research Site Elizabeth Vale 5112 Australia Details
Research Site North Adelaide 5000 Australia Details
Research Site Syndey 4032 Australia Details
Research Site Beijing 100142 China Details
Research Site Guangzhou 510060 China Details
Research Site Nanjing 2100008 China Details
Research Site Nanning 530021 China Details
Research Site Shanghai 200032 China Details
Research Site Xiamen 361003 China Details
Research Site Batumi 6010 Georgia Details
Research Site Tbilisi 0112 Georgia Details
Research Site Tbilisi 0114 Georgia Details
Research Site Tbilisi 0186 Georgia Details
Research Site Busan 48108 South Korea Details
Research Site Seongnam-si 13496 South Korea Details
Research Site Seongnam-si 13620 South Korea Details
Research Site Seoul 03080 South Korea Details
Research Site Seoul 03722 South Korea Details
Research Site Seoul 06591 South Korea Details
Research Site Seoul 5505 South Korea Details
Research Site Kaohsiung City 833401 Taiwan Details
Research Site Taichung 404327 Taiwan Details
Research Site Taichung 40705 Taiwan Details
Research Site Tainan 704 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field